Leo Rasche, Carolina D. Schinke, Cyrille Touzeau, Monique Minnema, Niels W.C.J. van de Donk, Paula Rodriguez-Otero, María-Victoria Mateos, Jing Christine Ye, Chalmer Tomlinson, Deeksha Vishwamitra, Indrajeet Singh, Xiang Qin, Michela Campagna, Tara J. Masterson, Veronique Vreys, Bonnie W. Lau, Jaszianne A. Tolbert, Thomas Renaud, Christoph Heuck, Ajai Chari. "Efficacy and safety from the phase 1/2 MonumenTAL-1 study of talquetamab, a GPRC5D×CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma: Analyses at an extended median follow-up.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.7528